Fatal temozolomide induced aplastic anemia in a female with Glioblastoma multiforme : A case report and literature review

Abstract

Abstract When seeing patients on Temozolomide with pancytopenia, aplastic anemia secondary to the drug should be considered early in the differentials to avoid permanent hematological suppression.

Keywords

• aplastic anemia
• glioblastoma multiforme
• temozolomide